MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$88K
Net Income
-$24,079K
Net Profit Margin
-27362.50%
EPS
-$0.38
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Total revenue
88
30,917
861
836
Cost of product revenues
25
51
49
46
Research and development
16,590
16,823
14,027
13,853
Selling, general and administrative
5,829
7,289
7,098
6,264
Total expenses
22,444
24,163
21,174
20,163
Gain from operations
-22,356
6,754
-20,313
-19,327
Interest (expense) income, net
-1,768
-763
-515
-36
Change in the fair value of derivative liability
324
254
-
-
Gain on sale of strategic investments
45
-
-
-
Total other (expense) income
-1,399
-509
-515
-36
Net gain
-23,755
6,245
-20,828
-19,363
Unrealized gain (loss) on marketable securities
-
-
29
-21
Adjustment to carrying value of series a preferred stock
324
247
-
-
Comprehensive loss
-
-
-20,799
-19,384
Net loss attributable to common stockholders
-24,079
5,998
-
-
Basic EPS
-0.38
0.096
-0.4
-0.5
Diluted EPS
-0.38
0.096
-0.4
-0.5
Basic Average Shares
63,812,098
62,173,684
52,186,503
38,392,716
Diluted Average Shares
63,812,098
62,173,684
52,186,503
38,392,716
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
OBIO Income Statement Sankey Diagram
Sankey diagram visualizing OBIO income statement for the period
Net loss
attributable to common...
-$24,079K
Net gain
-$23,755K
(-22.68%↓ Y/Y)
Adjustment to carrying
value of series a...
$324K
Gain from operations
-$22,356K
(-15.67%↓ Y/Y)
Total other (expense)
income
-$1,399K
(-3786.11%↓ Y/Y)
Total revenue
$88K
(-89.47%↓ Y/Y)
Change in the fair value
of derivative...
$324K
Gain on sale of
strategic investments
$45K
Total expenses
$22,444K
(11.31%↑ Y/Y)
Interest (expense)
income, net
-$1,768K
(-4811.11%↓ Y/Y)
Research and development
$16,590K
(19.76%↑ Y/Y)
Selling, general and
administrative
$5,829K
(-6.94%↓ Y/Y)
Cost of product
revenues
$25K
(-45.65%↓ Y/Y)
Buy us a coffee
Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO)